Distinguishing verrucous herpes from neoplastic lesions: A clinical and histopathological approach. [PDF]
Vattigunta M, Jaller JA.
europepmc +1 more source
Background and purpose Nano‐formulated chemotherapeutics prolong systemic availability of drugs and can reduce systemic toxicity, but their accumulation in solid tumours is often limited and unpredictable. Broadly applicable strategies to selectively enhance tumour delivery are lacking.
Annabel Kitowski +13 more
wiley +1 more source
Mycophenolate-Induced Colitis Complicated by Cytomegalovirus in an Immunocompromised Patient With Interstitial Lung Disease. [PDF]
Bara R +3 more
europepmc +1 more source
Babesiosis in non-immunocompromised versus immunocompromised patients
Cruz, Nicole M. +2 more
openaire +1 more source
Prevention of neuroinfectious-diseases: high impact of vaccination programs - but the potential is not maxed out yet. [PDF]
Klein M +6 more
europepmc +1 more source
Summary Background/objectives: Organ transplant recipients (OTRs) face an elevated risk of keratinocyte carcinomas (KC), leading to a lower threshold for biopsy. Line‐field confocal optical coherence tomography (LC‐OCT) is a non‐invasive imaging technique capable of visualizing malignant skin changes, yet its role in the management of OTRs remains ...
Kevin Jacobsen +4 more
wiley +1 more source
Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study. [PDF]
Tartof SY +20 more
europepmc +1 more source
Treatments for Molluscum contagiosum: A systematic review
Summary Molluscum contagiosum (MC) is a viral skin infection that poses significant physical and psychosocial burdens, particularly in pediatric and immunocompromised populations. Despite the availability of various treatment options, comparative efficacy and safety data remain limited.
Ou Jia (Emilie) Wang +3 more
wiley +1 more source
Understanding the Psychological Impacts of Shielding From COVID-19 for Immunocompromised Individuals. [PDF]
Gray A +3 more
europepmc +1 more source

